Entering text into the input field will update the search result below

Exelixis Inc (EXEL) CEO Michael Morrissey Presents at Goldman Sachs Global Healthcare Conference (Transcript)

Jun. 11, 2020 1:44 AM ETExelixis, Inc. (EXEL)
SA Transcripts profile picture
SA Transcripts

Exelixis Inc (NASDAQ:EXEL) Goldman Sachs Global Healthcare Conference June 10, 2020 2:10 PM ET

Company Participants

Michael Morrissey - President & CEO

Conference Call Participants

Paul Choi - Goldman Sachs

Paul Choi

Okay. Good afternoon, everyone. We'll continue with the next session. I'm Paul Choi, the mid-cap biotechnology analyst here at Goldman Sachs. And for our next session, I'm very pleased to host Exelixis. Joining us is the CEO, Mike Morrissey, and also on the line is Susan from Investor Relations.

And so as with our prior sessions, with Exelixis here, what we'll do is let Mike kick it off with some introductory remarks and then we'll go into the Q&A portion of the session. If along the way, if any clients or investors have questions for Mike and/or myself, please feel free to submit them through the Goldman Sachs Research portal and time permitting at the end we'll read one or two questions there. Alternatively, you can submit questions to me directly via e-mail. And again, if we have time, we'll try and squeeze them in at the end.

And so with that, Mike, I'll turn it over to you for some opening remarks. And then we'll go into the Q&A.

Michael Morrissey

Alright. Fantastic, Paul. Thanks again for the invite. Sorry, we couldn't do this live as usual down in LA but it's great to be on the call with you and your team today. Before I begin, I'll remind you that I'll be making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.

In terms of my kind of one minute overview, I think most of you know us. We are a 25-year old commercial-stage company -- biotech company focused on oncology. We have a long history of drug discovery, drug

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About EXEL

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on EXEL

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.